Smith & Nephew Wound Management announces that Gladase™, the company’s papain-urea debriding ointment, is now available for use with patients covered by Medicaid in all 50 states. This ensures that clinicians and patients have access to fast, effective, safe, and economical wound debridement. The ointment uses papain, a proteolytic enzyme derived from papayas, and urea, a denaturant of proteins, to remove necrotic tissue and liquefy slough in acute wounds, chronic wounds, infected wounds, carbuncles, and burns and contribute to the healing process.
       For more information, call (800) 876-1261 or visit http://www.smith-nephew.com.